So, in this “rapidly emerging” sector, isn’t pretty plausible that the “paradigm changing tech” is obsolete after 7yrs of ZERO R&D? Which may make the Canadien patent useless?
That’s probably not relevant “here”. Or somehow will be deflected onto the NSS, colluding entities, that target OTC companies and aren’t properly watched by the complicit SEC.